Maravai Lifesciences Holdings (MRVI) Change in Receivables (2020 - 2026)
Maravai Lifesciences Holdings (MRVI) posted quarterly Change in Receivables of $7.9 million for Q1 2026, up 177.89% year-over-year from $2.8 million in Q1 2025, and up 167.27% quarter-over-quarter from $3.0 million in Q4 2025.
Maravai Lifesciences Holdings (MRVI) Change in Receivables (2020 - 2026) Analysis & Trends
Maravai Lifesciences Holdings' Change in Receivables history runs 7 years deep, the most recent figure standing at $7.9 million for Q1 2026.
- In Q1 2026, Change in Receivables rose 177.89% year-over-year to $7.9 million; the TTM figure through Mar 2026 stood at $5.3 million (up 179.23% YoY), while the FY2025 annual figure was -$12.8 million, up 10.75% from the prior year.
- Change in Receivables for Q1 2026 stood at $7.9 million, up from $3.0 million in the prior quarter.
- The five-year high for Change in Receivables was $25.8 million in Q4 2022, with the low at -$82.4 million in Q1 2023.
- The 5-year median for Change in Receivables is -$1.9 million (2024), against an average of -$4.8 million.
- The sharpest annual moves came in 2023 and 2026: Change in Receivables slumped 6674.78% in 2023, then soared 177.89% in 2026.
- Maravai Lifesciences Holdings' Change in Receivables stood at $25.8 million in 2022, then tumbled by 65.92% to $8.8 million in 2023, then soared by 30.11% to $11.4 million in 2024, then plunged by 74.09% to $3.0 million in 2025, then jumped by 167.27% to $7.9 million in 2026.
- Business Quant data shows MRVI's Change in Receivables at $7.9 million in Q1 2026, $3.0 million in Q4 2025, and -$5.1 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 140.20 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 838.50 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 117.58 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -483,662.49 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 31.60 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 37.16 Mn |
| 10 | Maravai Lifesciences Holdings | 1.48 Bn | 1.56 Bn | 20.65 Mn | -2.29 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -2.29 Mn |
| Jun 30, 2026 | -2.29 Mn |
| Mar 31, 2026 | 7.91 Mn |
| Mar 31, 2026 | 7.91 Mn |
| Dec 31, 2025 | 2.96 Mn |
| Dec 31, 2025 | 2.96 Mn |
| Sep 30, 2025 | -5.12 Mn |
| Sep 30, 2025 | -5.12 Mn |
| Jun 30, 2025 | -501,000.00 |
| Jun 30, 2025 | -501,000.00 |
| Mar 31, 2025 | -10.16 Mn |
| Mar 31, 2025 | -10.16 Mn |
| Dec 31, 2024 | 11.43 Mn |
| Dec 31, 2024 | 11.43 Mn |
| Sep 30, 2024 | -6.02 Mn |
| Sep 30, 2024 | -6.02 Mn |
| Jun 30, 2024 | -1.89 Mn |
| Jun 30, 2024 | -1.89 Mn |
| Mar 31, 2024 | -17.88 Mn |
| Mar 31, 2024 | -17.88 Mn |